As of 2026-03-08, the Relative Valuation of Puma Biotechnology Inc (PBYI) is 14.40 USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.05 USD, the upside of Puma Biotechnology Inc based on Relative Valuation is 137.9%.
The range of the Relative Valuation is 9.40 - 20.47 USD.
| Range | Selected | |
| Trailing P/E multiples | 22.9x - 27.9x | 25.8x |
| Forward P/E multiples | 22.1x - 26.3x | 23.2x |
| Fair Price | 9.40 - 20.47 | 14.40 |
| Upside | 55.4% - 238.4% | 137.9% |
| Date | P/E |
| 2026-03-04 | 8.72 |
| 2026-03-03 | 8.46 |
| 2026-03-02 | 8.75 |
| 2026-02-27 | 7.77 |
| 2026-02-26 | 10.36 |
| 2026-02-25 | 10.47 |
| 2026-02-24 | 10.21 |
| 2026-02-23 | 9.69 |
| 2026-02-20 | 9.31 |
| 2026-02-19 | 9.25 |
| 2026-02-18 | 9.10 |
| 2026-02-17 | 9.20 |
| 2026-02-13 | 9.29 |
| 2026-02-12 | 9.27 |
| 2026-02-11 | 9.05 |
| 2026-02-10 | 9.01 |
| 2026-02-09 | 9.38 |
| 2026-02-06 | 9.46 |
| 2026-02-05 | 9.25 |
| 2026-02-04 | 9.68 |
| 2026-02-03 | 9.68 |
| 2026-02-02 | 9.29 |
| 2026-01-30 | 8.83 |
| 2026-01-29 | 8.76 |
| 2026-01-28 | 8.61 |
| 2026-01-27 | 8.95 |
| 2026-01-26 | 8.76 |
| 2026-01-23 | 8.75 |
| 2026-01-22 | 9.35 |
| 2026-01-21 | 9.39 |
| 2026-01-20 | 8.99 |
| 2026-01-16 | 8.68 |
| 2026-01-15 | 8.69 |
| 2026-01-14 | 8.75 |
| 2026-01-13 | 8.50 |
| 2026-01-12 | 8.56 |
| 2026-01-09 | 8.33 |
| 2026-01-08 | 8.45 |
| 2026-01-07 | 8.30 |
| 2026-01-06 | 7.99 |
| 2026-01-05 | 8.09 |
| 2026-01-02 | 7.86 |
| 2025-12-31 | 8.11 |
| 2025-12-30 | 8.19 |
| 2025-12-29 | 8.30 |
| 2025-12-26 | 8.39 |
| 2025-12-24 | 8.12 |
| 2025-12-23 | 8.05 |
| 2025-12-22 | 7.94 |
| 2025-12-19 | 7.67 |